Search results for "COMORBIDITY"

showing 10 items of 799 documents

Depression bei Kindern und Jugendlichen: Prävalenz, Diagnostik, ätiologische Faktoren, Geschlechtsunterschiede, therapeutische Ansätze

2007

Die Prävalenzraten für die verschiednen Formen von Depression (depressiven Stimmungen, depressiven Syndromen und Major Depression) haben in den letzten Jahren zugenommen, die Geschlechtsunterschiede mit deutlich höheren Raten für Mädchen haben sich erhöht. Als ätiologische Faktoren für das Auftreten von Depression werden u. a. zunehmende Stressfaktoren, dysfunktionale Bewältigungsstile, ein negatives Körperkonzept und unsichere Bindungsmuster genannt. Unter den verschiedenen therapeutischen Ansätzen hat sich die psychoananlytische Behandlungsmethode als die umfassendste erwiesen. Schlüsselwörter Prävalenzraten - Komorbidität - Stress - Coping - Körperkonzept - Bindung Prevalence rates of th…

Coping (psychology)medicine.medical_specialtyGeschlechtsunterschiedPsychologische MessungDepression (Emotion)EtiologyCross-sectional studyEpidemiologyKindDysfunctional familyHuman Sex DifferencesRisk FactorsEpidemiologyNegative body imageMajor DepressionmedicinePsychological testingPsychiatryGeschlechtsunterschiede beim MenschenEpidemiologieDepressive StimmungDepressionPsychological Assessmentmedicine.diseasePsychotherapieComorbidityPsychotherapyEtiologyJugendPsychologyClinical psychologyÄtiologiePsychologische Diagnostik
researchProduct

The German CPU Registry: Dyspnea independently predicts negative short-term outcome in patients admitted to German Chest Pain Units.

2015

While dyspnea is a common symptom in patients admitted to Chest Pain Units (CPUs) little is known about the impact of dyspnea on their outcome. The purpose of this study was to evaluate the impact of dyspnea on the short-term outcome of CPU patients.We analyzed data from a total of 9169 patients admitted to one of the 38 participating CPUs in this registry between December 2008 and January 2013. Only patients who underwent coronary angiography for suspected ACS were included. 2601 patients (28.4%) presented with dyspnea.Patients with dyspnea at admission were older and frequently had a wide range of comorbidities compared to patients without dyspnea. Heart failure symptoms in particular wer…

Coronary angiographyMalemedicine.medical_specialtyAcute coronary syndromeChest PainMedizinComorbidityChest painCoronary AngiographyRisk AssessmentPredictive Value of TestsRisk FactorsInternal medicineGermanymedicineHumansIn patientRegistriesAcute Coronary SyndromeMortalityAgedHeart Failurebusiness.industryAge Factorsmedicine.diseasePrognosisComorbidityrespiratory tract diseases3. Good healthDyspneaHeart failurePredictive value of testsPhysical therapyFemalemedicine.symptomCardiology and Cardiovascular MedicineRisk assessmentbusinessInternational journal of cardiology
researchProduct

There is a relationship between obesity and COVID‐19 but more information is needed

2020

Abstract We read with particular interest your comments in Obesity regarding the Coronavirus‐19 (COVID‐19) epidemic (1) and a related manuscript by Simonnet et al. (2). Resolution of the specific relationship between obesity and COVID‐19, two existing public health epidemics, is critically needed to potentially prevent health systems worldwide from being overburdened. Few studies describing COVID‐19 with rates of obesity exist, and most are based on heterogeneous populations (Table 1) (2‐7). In cohort studies with COVID‐19 disease, obesity rates are generally reported as no higher than population‐based estimates; in contrast, subgroups of critically ill patients (e.g, intensive care unit (I…

Critical CareSARS-CoV-2Pneumonia ViralCOVID-19Social SupportComorbiditySeverity of Illness Indexobesity COVID-19 incidence prevalenceUnited StatesBetacoronavirusSocial IsolationRisk FactorsHumansObesitySettore MED/49 - Scienze Tecniche Dietetiche ApplicateLetters to the EditorCoronavirus InfectionsLetter to the EditorPandemicsObesity (Silver Spring, Md.)
researchProduct

Growing old with antiretroviral therapy or elderly people in antiretroviral therapy: two different profiles of comorbidity?

2022

Abstract Background In persons living with HIV (PLWH), the burden of non-communicable chronic diseases increased over time, because of aging associated with chronic inflammation, systemic immune activation, and long-term exposure to the combination antiretroviral therapy (ART). Methods To explore the association of chronological age, age at first ART, and exposure to ART with non-communicable chronic diseases, we performed a cross-sectional analysis to evaluate the prevalence of comorbidities in patients enrolled in the SCOLTA Project, stratified by groups of chronological age (50–59 and 60–69 years) and by years of antiretroviral treatment (ART, ≤ 3 or > 3 years). Results In 1394 subjec…

Cross-Sectional StudieMaleART exposureHIVMultimorbidityHIV InfectionsComorbidityOsteoporosis.Noncommunicable DiseaseBone Diseases MetabolicCross-Sectional StudiesInfectious DiseasesAgeAnti-Retroviral AgentsHypertensionHumansOsteoporosisAnti-Retroviral AgentFemaleHIV InfectionNoncommunicable DiseasesAgedHuman
researchProduct

Mapping of global scientific research in comorbidity and multimorbidity: A cross-sectional analysis

2018

[Background]: The management of comorbidity and multimorbidity poses major challenges to health services around the world. Analysis of scientific research in comorbidity and multimorbidity is limited in the biomedical literature. This study aimed to map global scientific research in comorbidity and multimorbidity to understand the maturity and growth of the area during the past decades. [Methods and findings]: This was a cross-sectional analysis of the Web of Science. Searches were run from inception until November 8, 2016. We included research articles or reviews with no restrictions by language or publication date. Data abstraction was done by one researcher. A process of standardization …

Cross-sectional studylcsh:MedicineComorbidity030204 cardiovascular system & hematologyGeographical locations0302 clinical medicineEndocrinologyCitation analysisMedicine and Health Sciences030212 general & internal medicinelcsh:ScienceGeriatricsMultidisciplinaryDepressionHealth services researchResearch AssessmentPatologia3. Good healthCitation AnalysisHealth Services ResearchPsychologyResearch Articlemedicine.medical_specialtyEndocrine DisordersSpecialtyMEDLINEImpacteResearch and Analysis Methods03 medical and health sciencesBibliometriamental disordersMental Health and PsychiatrymedicineDiabetes MellitusHumansMood DisordersResearchlcsh:Rmedicine.diseaseComorbidityUnited StatesHealth CareCross-Sectional StudiesGeriatricsFamily medicineNational Comorbidity SurveyMetabolic DisordersNorth Americalcsh:QPeople and placesPLoS ONE
researchProduct

Real-world effectiveness of ombitasvir/paritaprevir/ritonavir±dasabuvir±ribavirin in patients with hepatitis C virus genotype 1 or 4 infection: A met…

2017

The direct-acting antiviral regimen of ombitasvir (OBV)/paritaprevir (PTV)/ritonavir (r) ± dasabuvir (DSV) ± ribavirin (RBV) demonstrated high rates of sustained viral response at post-treatment week 12 (SVR12) in clinical trials for treatment of hepatitis C virus (HCV) genotypes (GT) 1 and 4. To confirm the effectiveness of this regimen in the real world, we conducted meta-analyses of published literature on 30 April 2016. Freeman-Tukey transformation determined the SVR rate within GTs 1a, 1b, and 4, as well as specific SVR rates by cirrhosis or prior treatment experience status. Rates of virologic relapse, hepatic decompensation, drug discontinuation, and serious adverse events were also …

CyclopropanesLiver CirrhosisSustained Virologic ResponseHCV genotypes 1 and 4ComorbidityHepacivirusmedicine.disease_causeGastroenterologymeta-analysichemistry.chemical_compound0302 clinical medicineAnilides030212 general & internal medicineSulfonamidesDasabuvirValineHepatitis CViral LoadHepatitis Creal-world effectiveneInfectious DiseasesTreatment Outcome2D; 3D; HCV genotypes 1 and 4; hepatitis C; meta-analysis; real-world effectiveness; Hepatology; Infectious Diseases; Virology030211 gastroenterology & hepatologyDrug Therapy Combinationmedicine.drug3Dmedicine.medical_specialtyMacrocyclic CompoundsGenotypeProlineHepatitis C virusLactams MacrocyclicInfectious DiseaseAntiviral Agents03 medical and health sciencesInternal medicineVirologyRibavirinmedicineHumans2DRitonavirHepatologybusiness.industryRibavirinmedicine.diseaseOmbitasvirRegimenchemistryParitaprevirImmunologyRitonavirCarbamatesbusinessJournal of viral hepatitis
researchProduct

Use of the KSVM-based system for the definition, validation and identification of the incisional hernia recurrence risk factors

2019

BACKGROUND: Incisional hernia is one of the most common complications after abdominal surgery with an incidence rate of 11 to 20% post laparotomy. Many different factors can be considered as risk factors of incisional hernia recurrence. The aim of this study is to confirm and to validate the incisional hernia recurrence risk factors and to identify and to validate new ones. METHODS: In the period from July 2007 to July 2017, 154 patients were selected and subjected to incisional hernia repair. The surgical operations were conducted under general anaesthesia. Patients received antibiotic prophylaxis when indicated, according to the hospital prophylaxis scheme. Inclusion criteria of the study…

Data AnalysisMaleAge FactorsDatasets as TopicIncisional hernia - Risk factors - Recurrence - KSVM.ComorbidityAnesthesia GeneralAntibiotic ProphylaxisMiddle AgedSensitivity and SpecificityBody Mass IndexMachine LearningSex Factorssurgical procedures operativeRecurrenceRisk Factorsincisional hernia risk factorsData MiningHumansIncisional HerniaFemale
researchProduct

The Importance of the Nurse’s Role in the Management of Complex Diabetic Outpatients: It is the Time to Manage Patient’s Multidimensions

2018

none

Diabetes Quality of lifemedicine.medical_specialtyUltrasound scanComorbiditylaw.invention03 medical and health sciences0302 clinical medicineClinical pathwaylawMedicineTherapeutic ReconciliationClinical ComplexityNursing AssessmentDepression (differential diagnoses)PolypharmacyClinical pharmacology030214 geriatricsbusiness.industryOutpatientDiabetes MellituGeneral MedicineSettore MED/45 - Scienze Infermieristiche Generali Cliniche E PediatrichePatient Care ManagementNutritionistChronic DiseasePhysical therapyGeriatric Depression ScalebusinessBioelectrical impedance analysisNeeds AssessmentBiomedical Journal of Scientific & Technical Research
researchProduct

Common Neural Mechanisms of Palatable Food Intake and Drug Abuse: Knowledge Obtained with Animal Models

2019

Eating is necessary for survival, but it is also one of the great pleasures enjoyed by human beings. Research to date shows that palatable food can be rewarding in a similar way to drugs of abuse, indicating considerable comorbidity between eating disorders and substance-use disorders. Analysis of the common characteristics of both types of disorder has led to a new wave of studies proposing a Gateway Theory of food as a vulnerability factor that modulates the development of drug addiction. The homeostatic and hedonic mechanisms of feeding overlap with some of the mechanisms implicated in drug abuse and their interaction plays a crucial role in the development of drug addiction. Studies in…

DrugDrugs of abuseFood intakeSubstance-Related Disordersmedia_common.quotation_subjectDevelopmental psychologyEating03 medical and health sciences0302 clinical medicineRewardDrug DiscoverymedicineAnimalsHumans030304 developmental biologymedia_commonPharmacology0303 health sciencesAddictionFeeding Behaviormedicine.diseaseComorbidityObesitySubstance abuseEating disordersModels AnimalPsychology030217 neurology & neurosurgeryCurrent Pharmaceutical Design
researchProduct

Use of ICS/LABA (extra-fine and non-extra-fine) in elderly asthmatics.

2016

Age represents an exclusion criterion in randomized clinical trials designed to test the efficacy and safety of inhaled drugs in asthma. As a consequence, data on efficacy and safety of inhaled corticosteroid (ICS) and long-acting β2 agonist (LABA) combinations in elderly asthmatics are scanty. Older age is associated with an increased proportion of comorbid conditions; in addition, all organ functions undergo a process of senescence, thus reducing their ability to metabolize the agents. Overall, these age-associated conditions may variably, and often unpredictably, affect the metabolism and excretion of respiratory drugs. However, pharmacological treatment of asthma does not follow specifi…

Druglong-acting β2 agonistmedicine.medical_specialtyasthma treatmentmedia_common.quotation_subjectPopulationReviewSettore MED/10 - Malattie Dell'Apparato Respiratorio030204 cardiovascular system & hematologylaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled trialPharmacokineticsInhaled corticosteroidlawmedicinePharmacology (medical)General Pharmacology Toxicology and PharmaceuticseducationAdverse effectIntensive care medicineAsthmamedia_commoneducation.field_of_studyChemical Health and SafetyInhalationbusiness.industryaginglung functionGeneral Medicinemedicine.diseasecomorbidity030228 respiratory systemAnesthesiaPharmacodynamicslong-acting β2 agonistsinhaled corticosteroidsbusinessSafety ResearchTherapeutics and clinical risk management
researchProduct